Skip to main content
. Author manuscript; available in PMC: 2018 Jul 1.
Published in final edited form as: Pharmacogenomics J. 2016 Mar 15;17(4):351–359. doi: 10.1038/tpj.2016.18

Fig. 2. TSA was identified as a drug candidate in four datasets.

Fig. 2

TSA DRS profile is prognostic in the (A) Herold dataset, (B) Verhaak dataset, (C) Valk dataset, (D) and William dataset with p<0.01. Patients were stratified at DRS = 0